- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.24: 3 residues within 4Å:- Chain A: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain A: N.120, T.122, V.125, F.152
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.160
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: G.229, N.231
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: N.279
- Chain C: K.555
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: D.336, N.340
- Ligands: NAG.30
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Ligands: NAG.29
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: N.613, T.615, Q.641
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: Y.652, N.654
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain A: N.706, I.1127, G.1128
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: N.120, T.122
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.160
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: G.229, N.231
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.279
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Ligands: NAG-NAG.8
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: N.613, T.615, Q.641
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain B: Y.652, N.654
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain B: A.703, E.1069, N.1071
- Ligands: NAG.45
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Ligands: NAG.44
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain C: N.120, T.122, V.125
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.160
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: G.229, N.231
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.279
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Ligands: NAG-NAG.15
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: N.613, Q.641
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: Y.652, N.654
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain D: N.102, T.104
Ligand excluded by PLIPNAG.56: 4 residues within 4Å:- Chain D: Q.113, Q.114, N.115, V.119
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain D: E.324, V.328, N.334
Ligand excluded by PLIPNAG.58: 1 residues within 4Å:- Chain D: N.444
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain D: S.329, N.558
- Ligands: NAG.60
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Ligands: NAG.59, NAG.61
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Ligands: NAG.60
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain E: N.102, T.104
Ligand excluded by PLIPNAG.63: 4 residues within 4Å:- Chain E: Q.113, Q.114, N.115, V.119
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain E: E.324, V.328, N.334
Ligand excluded by PLIPNAG.65: 1 residues within 4Å:- Chain E: N.444
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain E: S.329, N.558
- Ligands: NAG.67
Ligand excluded by PLIPNAG.67: 2 residues within 4Å:- Ligands: NAG.66, NAG.68
Ligand excluded by PLIPNAG.68: 1 residues within 4Å:- Ligands: NAG.67
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Y. et al., Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants. Iscience (2022)
- Release Date
- 2022-06-15
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Y. et al., Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants. Iscience (2022)
- Release Date
- 2022-06-15
- Peptides
- Spike glycoprotein: ABC
Angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E